Delivery Order SPE2DB20D7059-SPE2DB25FQMS6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,749.25 to supply Dexcom G7 sensors, with an ultimate completion date of July 29, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $1,635.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of July 30, 2025. This non-set-aside competitive award was issued on July 29, 2025, with performance conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical...
- The Defense Logistics Agency awarded a $6,788.95 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,062.40 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with performance completed by August 5, 2025. This firm fixed price contract was awarded on August 4, 2025, without set-aside designation and represents a competitively awarded procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,390.30 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. This competitive award, issued on July 30, 2025, with a completion date of July 31, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a $1,008.89 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 4, 2025. This is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and performance will be executed from...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion expected by July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive, non-set-aside award for continuous glucose monitoring devices to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price, non-competitive delivery order is being performed at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- The Defense Logistics Agency awarded a delivery order valued at $3,405.38 to AmerisourceBergen Drug Corp for Dexcom G6 Sensor 3S continuous glucose monitoring devices. This contract was competitively awarded with no set-aside designation and employs firm fixed pricing, with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location. The delivery order is issued under the company's...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQMS6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,361.44 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that serves military healthcare programs globally. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that has demonstrated consistent capability to fulfill DLA requirements through competitive award processes. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The Dexcom G7 sensors represent the company's ongoing role in supplying specialized medical devices and diabetes management products to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through the flexible pharmaceutical prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/5/25 |